IGF1 and myeloid neoplasm: Although increasing attention has been paid to IGF-related pathways in these diseases, much of the current understanding is extrapolated from studies in solid tumors, and the specific roles of IGF signaling in the pathogenesis of myeloid neoplasms remain to be fully elucidated (26, 27).